Search research articles
Contact Us
Filters
Showing results (21-30 of 86) with videos related to
Page
of 9
Sort By:
Menopause (New York, N.Y.)
|
January 10, 2012
An empirically validated responder definition for the reduction of moderate to severe hot flushes in postmenopausal women
Christoph Gerlinger, Kerstin Gude, Florian Hiemeyer, et al.
Journal of Patient-Reported Outcomes
|
February 17, 2025
Comparative performance of PROMIS Sleep Disturbance computerized adaptive testing algorithms and static short form in postmenopausal women
Andrew Trigg, Claudia Haberland, Huda Shalhoub, et al.
Pharmaceutical Statistics
|
October 19, 2013
European Federation of Statisticians in the Pharmaceutical Industry's position on access to clinical trial data
Christine Fletcher, Stefan Driessen, Hans Ulrich Burger, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception
|
December 3, 2020
Predicting menstrual bleeding patterns with levonorgestrel-releasing intrauterine systems
Ann-Kathrin Frenz, Christiane Ahlers, Vita Beckert, et al.
Menopause (New York, N.Y.)
|
August 22, 2013
A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women
David F Archer, Thomas Schmelter, Matthias Schaefers, et al.
Contraception
|
March 15, 2006
A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol
Cornelis Kluft, Jan Endrikat, Simone M Mulder, et al.
Fertility and Sterility
|
December 17, 2013
Validation of a new menstrual pictogram (superabsorbent polymer-c version) for use with ultraslim towels that contain superabsorbent polymers
Julia L Magnay, Tracy M Nevatte, Shaughn O'Brien, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception
|
September 1, 2007
A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 microg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight
Jan Endrikat, Mirella Sandri, Christoph Gerlinger, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|
February 23, 2026
Integration of Real-World Data into Clinical Trials: An Interdisciplinary Discussion from Regulatory and Practical Perspectives
Jeanette Köppe, Anja Schiel, Christoph Gerlinger, et al.
International Journal of Women'S Health
|
May 1, 2015
Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program
Thomas Strowitzki, Thomas Faustmann, Christoph Gerlinger, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 86) with videos related to
Sort By:
Page
of 9
Menopause (New York, N.Y.)
|
January 10, 2012
An empirically validated responder definition for the reduction of moderate to severe hot flushes in postmenopausal women
Christoph Gerlinger, Kerstin Gude, Florian Hiemeyer, et al.
Journal of Patient-Reported Outcomes
|
February 17, 2025
Comparative performance of PROMIS Sleep Disturbance computerized adaptive testing algorithms and static short form in postmenopausal women
Andrew Trigg, Claudia Haberland, Huda Shalhoub, et al.
Pharmaceutical Statistics
|
October 19, 2013
European Federation of Statisticians in the Pharmaceutical Industry's position on access to clinical trial data
Christine Fletcher, Stefan Driessen, Hans Ulrich Burger, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception
|
December 3, 2020
Predicting menstrual bleeding patterns with levonorgestrel-releasing intrauterine systems
Ann-Kathrin Frenz, Christiane Ahlers, Vita Beckert, et al.
Menopause (New York, N.Y.)
|
August 22, 2013
A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women
David F Archer, Thomas Schmelter, Matthias Schaefers, et al.
Contraception
|
March 15, 2006
A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol
Cornelis Kluft, Jan Endrikat, Simone M Mulder, et al.
Fertility and Sterility
|
December 17, 2013
Validation of a new menstrual pictogram (superabsorbent polymer-c version) for use with ultraslim towels that contain superabsorbent polymers
Julia L Magnay, Tracy M Nevatte, Shaughn O'Brien, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception
|
September 1, 2007
A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 microg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight
Jan Endrikat, Mirella Sandri, Christoph Gerlinger, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|
February 23, 2026
Integration of Real-World Data into Clinical Trials: An Interdisciplinary Discussion from Regulatory and Practical Perspectives
Jeanette Köppe, Anja Schiel, Christoph Gerlinger, et al.
International Journal of Women'S Health
|
May 1, 2015
Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program
Thomas Strowitzki, Thomas Faustmann, Christoph Gerlinger, et al.
Page
of 9